- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 677.75M sh |
| Shares Outstanding | Q1 2025 · Dec 31, 2024 | 666.42M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.01B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.01B |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $1.59B |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $1.7B |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.16B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $711.68M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $310.69M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $221.45M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $3.82B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $3.66B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $7.16B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $6.97B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.89B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.73B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $7.45B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $7.18B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 635.02M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $46.68M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $238.95M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.43 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.43 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $97.82M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $362.07M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$270.6M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$302.33M |
| Revenue | Q1 2025 · Mar 31, 2024 | $801.3M |